Moderna shares soar 60% on melanoma vaccine trial success
- Posted on August 19, 2026
- By Financial Times
- 0 Views
- 1 min read
In brief
Generating AI summary…
Moderna shares soar 60% on melanoma vaccine trial success
Company’s melanoma cancer vaccine being developed with Merck